Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02545478 · ClinicalTrials.gov registry record
Biomarkers in Infection
A clinical trial of Inflammation and Sepsis, sponsored by Beth Israel Deaconess Medical Center.
- Recruiting
- Registry status
- 4,200
- Enrollment target
- 2
- Study locations
NCT02545478: Recruiting study of Inflammation and Sepsis, sponsored by Beth Israel Deaconess Medical Center.
NCT02545478 is a study of Inflammation and Sepsis that is actively recruiting participants, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 4,200 participants, above the 256-participant average among 132 other Inflammation trials with a reported enrollment target (1541% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02545478, a study of Inflammation and Sepsis, is actively recruiting participants, sponsored by Beth Israel Deaconess Medical Center.
- RECRUITING
- Registry status
- 4,200 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this investigation is to evaluate how early biomarkers of infection and inflammation perform in identifying patients at risk for poor outcome in sepsis and septic shock.
Primary Outcome
participants will be followed up for 28 days
Conditions Studied
Study Locations (2)
Massachusetts
- Massachusetts General Hospital - Boston
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,200 participants |
| Start Date | 2006-04 |
| Est. Completion | 2028-12 |
What NCT02545478 shows while recruiting
NCT02545478 is an observational study that tracks outcomes without assigning an intervention. Its 4,200 participants enrollment target places it among the larger protocols in the corpus, above the 256-participant average among 132 other Inflammation trials with a reported enrollment target (1541% higher).
The record links to 3 conditions, with Inflammation appearing as the primary indexed condition, and to 0 interventions.
NCT02545478 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02545478 about?
NCT02545478 is a clinical study titled "Biomarkers in Infection". The purpose of this investigation is to evaluate how early biomarkers of infection and inflammation perform in identifying patients at risk for poor outcome in sepsis and septic shock.
What is the current status of trial NCT02545478?
This trial is currently recruiting. The enrollment target is 4,200 participants. The study started on 2006-04. Estimated completion is 2028-12.
What conditions does trial NCT02545478 study?
This clinical trial studies the following conditions: Inflammation, Sepsis, Infection.
Who is sponsoring clinical trial NCT02545478?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02545478 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02545478's enrollment target sits among peer trials
4,200 3rd of 132 higher than 130 of 132 other Inflammation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Inflammation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
Reducing Frailty for Older Cancer Survivors Using Supplements II
RECRUITING · Phase 2
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
RECRUITING · Phase 3
-
Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02693535 · 4,200 participants · Phase 2
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- NCT05969028 · 4,200 participants · NA
First Responder Airway & Compression Rate Trial
- NCT06935370 · 4,200 participants · Phase 3
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- NCT07209098 · 4,200 participants
Propensity-Matched Study of Cardiac Contractility Modulation Therapy in Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia